{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:56:54Z","timestamp":1791572214672,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Selective Mutism (SM) is a rare childhood anxiety disorder characterized by a persistent inability to speak in specific social settings despite adequate speaking ability in others, sharing etiological and clinical overlap with Social Anxiety Disorder (SAD). While evidence for pharmacological treatment in SM is limited, selective serotonin reuptake inhibitors (SSRIs) have demonstrated potential efficacy, but studies on effectiveness in routine clinical practice are lacking. This single-center, retrospective observational study analysed data from 2011 to 2021 on children aged 4\u201314\u00a0years with SM or SAD treated as inpatients at a German university hospital. The mean age at admission was 11.9\u00a0years in both groups. Using propensity score matching and statistical modelling, we compared SSRI prescription patterns, dosage, and duration of inpatient\/day-care treatment (DOT) between groups. In the SM group, we additionally tested for differences in speaking pattern at discharge comparing children with and without SSRI medication. SSRI treatment was more frequent in SM (75.4%) than in SAD (55.0%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.011). Adjusted for pattern of additional internalizing, externalizing and specific developmental disorders, no main effects of group (SM versus SAD), nor of SSRI treatment or dosage between and across groups were found on DOT. In the SM group, SSRI treatment was associated with more strongly improved speaking pattern at discharge compared to treatment without SSRI (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.009). Results are discussed in relation to optimal dosage and effectiveness of SSRI treatment on improved speaking pattern in SM.\n                  <\/jats:p>","DOI":"10.1007\/s00787-025-02950-z","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:53:53Z","timestamp":1768553633000},"page":"1533-1544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of selective serotonin reuptake inhibitors in inpatients with selective mutism compared to social anxiety disorder: an observational study"],"prefix":"10.1007","volume":"35","author":[{"given":"Charlotte","family":"Sachs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3429-8306","authenticated-orcid":false,"given":"Simeon","family":"Platte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7329-9985","authenticated-orcid":false,"given":"Andreas G.","family":"Chiocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9676-4782","authenticated-orcid":false,"given":"Christine M.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2950_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1469-7610.2005.01560.x","volume":"47","author":"H-C Steinhausen","year":"2006","unstructured":"Steinhausen H-C, Wachter M, Laimb\u00f6ck K et al (2006) A long-term outcome study of selective mutism in childhood. J Child Psychol Psychiatry 47:751\u2013756. https:\/\/doi.org\/10.1111\/j.1469-7610.2005.01560.x","journal-title":"J Child Psychol Psychiatry"},{"key":"2950_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00787-014-0620-1","volume":"24","author":"B Oerbeck","year":"2015","unstructured":"Oerbeck B, Stein MB, Pripp AH et al (2015) Selective mutism: follow-up study 1 year after end of treatment. Eur Child Adolesc Psychiatry 24:757\u2013766. https:\/\/doi.org\/10.1007\/s00787-014-0620-1","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2950_CR3","unstructured":"(2017, 2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th ed. American Psychiatric Association, Arlington, VA"},{"key":"2950_CR4","unstructured":"World Health Organization (2022) \u201cInternational Classification of Diseases, Eleventh Revision (ICD-11)\u201d Accessed 24 Jul 2022"},{"key":"2950_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00787-021-01777-8","volume":"31","author":"C Schwenck","year":"2022","unstructured":"Schwenck C, Gensthaler A, Vogel F et al (2022) Characteristics of person, place, and activity that trigger failure to speak in children with selective mutism. Eur Child Adolesc Psychiatry 31:1419\u20131429. https:\/\/doi.org\/10.1007\/s00787-021-01777-8","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2950_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100644","volume":"19","author":"C Rodrigues Pereira","year":"2020","unstructured":"Rodrigues Pereira C, Ensink JBM, G\u00fcldner MG et al (2020) Effectiveness of a behavioral treatment protocol for selective mutism in children: design of a randomized controlled trial. Contemp Clin Trials Commun 19:100644. https:\/\/doi.org\/10.1016\/j.conctc.2020.100644","journal-title":"Contemp Clin Trials Commun"},{"key":"2950_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00787-016-0835-4","volume":"25","author":"A Gensthaler","year":"2016","unstructured":"Gensthaler A, Khalaf S, Ligges M et al (2016) Selective mutism and temperament: the silence and behavioral inhibition to the unfamiliar. Eur Child Adolesc Psychiatry 25:1113\u20131120. https:\/\/doi.org\/10.1007\/s00787-016-0835-4","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2950_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17113941","volume":"17","author":"G-L Luis-Joaquin","year":"2020","unstructured":"Luis-Joaquin G-L, Lourdes E-F, Jos\u00e9 AM-M (2020) Behavioral inhibition in childhood as a risk factor for development of social anxiety disorder: a longitudinal study. Int J Environ Res Public Health 17:3941. https:\/\/doi.org\/10.3390\/ijerph17113941","journal-title":"Int J Environ Res Public Health"},{"key":"2950_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10567-020-00342-0","volume":"24","author":"P Muris","year":"2021","unstructured":"Muris P, Ollendick TH (2021) Selective mutism and its relations to social anxiety disorder and autism spectrum disorder. Clin Child Fam Psychol Rev 24:294\u2013325. https:\/\/doi.org\/10.1007\/s10567-020-00342-0","journal-title":"Clin Child Fam Psychol Rev"},{"key":"2950_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2020.103696","volume":"133","author":"MI Milic","year":"2020","unstructured":"Milic MI, Carl T, Rapee RM (2020) Similarities and differences between young children with selective mutism and social anxiety disorder. Behav Res Ther 133:103696. https:\/\/doi.org\/10.1016\/j.brat.2020.103696","journal-title":"Behav Res Ther"},{"key":"2950_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00787-019-01281-0","volume":"28","author":"F Vogel","year":"2019","unstructured":"Vogel F, Gensthaler A, Stahl J et al (2019) Fears and fear-related cognitions in children with selective mutism. Eur Child Adolesc Psychiatry 28:1169\u20131181. https:\/\/doi.org\/10.1007\/s00787-019-01281-0","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2950_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00115-018-0504-6","volume":"89","author":"J Rogoll","year":"2018","unstructured":"Rogoll J, Petzold M, Str\u00f6hle A (2018) Selektiver Mutismus (Selective mutism). Nervenarzt 89:591\u2013602. https:\/\/doi.org\/10.1007\/s00115-018-0504-6","journal-title":"Nervenarzt"},{"key":"2950_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1037\/1045-3830.23.3.354","volume":"23","author":"JS Carlson","year":"2008","unstructured":"Carlson JS, Mitchell AD, Segool N (2008) The current state of empirical support for the pharmacological treatment of selective mutism. Sch Psychol Q 23:354\u2013372. https:\/\/doi.org\/10.1037\/1045-3830.23.3.354","journal-title":"Sch Psychol Q"},{"key":"2950_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10567-015-0181-y","volume":"18","author":"P Muris","year":"2015","unstructured":"Muris P, Ollendick TH (2015) Children who are anxious in silence: a review on selective mutism, the new anxiety disorder in DSM-5. Clin Child Fam Psychol Rev 18:151\u2013169. https:\/\/doi.org\/10.1007\/s10567-015-0181-y","journal-title":"Clin Child Fam Psychol Rev"},{"key":"2950_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00787-015-0794-1","volume":"25","author":"K Manassis","year":"2016","unstructured":"Manassis K, Oerbeck B, Overgaard KR (2016) The use of medication in selective mutism: a systematic review. Eur Child Adolesc Psychiatry 25:571\u2013578. https:\/\/doi.org\/10.1007\/s00787-015-0794-1","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2950_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/08039488.2022.2075460","volume":"77","author":"\u00cdH Stef\u00e1nsd\u00f3ttir","year":"2023","unstructured":"Stef\u00e1nsd\u00f3ttir \u00cdH, Ivarsson T, Skarphedinsson G (2023) Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis. Nord J Psychiatry 77:137\u2013146. https:\/\/doi.org\/10.1080\/08039488.2022.2075460","journal-title":"Nord J Psychiatry"},{"key":"2950_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/da.22329","volume":"32","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Welge JA, Wehry AM et al (2015) Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety 32:149\u2013157. https:\/\/doi.org\/10.1002\/da.22329","journal-title":"Depress Anxiety"},{"key":"2950_CR18","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13396","author":"JR Strawn","year":"2020","unstructured":"Strawn JR, Mills JA, Schroeder H et al (2020) Escitalopram in adolescents with generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychiatry. https:\/\/doi.org\/10.4088\/JCP.20m13396","journal-title":"J Clin Psychiatry"},{"key":"2950_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/da.22854","volume":"36","author":"E Jakubovski","year":"2019","unstructured":"Jakubovski E, Johnson JA, Nasir M et al (2019) Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Depress Anxiety 36:198\u2013212. https:\/\/doi.org\/10.1002\/da.22854","journal-title":"Depress Anxiety"},{"key":"2950_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/00004583-199507000-00008","volume":"34","author":"HH Wright","year":"1995","unstructured":"Wright HH, Cuccaro ML, Leonhardt TV et al (1995) Case study: fluoxetine in the multimodal treatment of a preschool child with selective mutism. J Am Acad Child Adolesc Psychiatry 34:857\u2013862. https:\/\/doi.org\/10.1097\/00004583-199507000-00008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2950_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-0031-1287776","volume":"45","author":"PL Plener","year":"2012","unstructured":"Plener PL, Gatz SA, Schuetz C et al (2012) A case of selective mutism in an 8-year-old girl with thalassaemia major after bone marrow transplantation. Pharmacopsychiatry 45:37\u201339. https:\/\/doi.org\/10.1055\/s-0031-1287776","journal-title":"Pharmacopsychiatry"},{"key":"2950_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00004583-199605000-00016","volume":"35","author":"ES Dummit","year":"1996","unstructured":"Dummit ES, Klein RG, Tancer NK et al (1996) Fluoxetine treatment of children with selective mutism: an open trial. J Am Acad Child Adolesc Psychiatry 35:615\u2013621. https:\/\/doi.org\/10.1097\/00004583-199605000-00016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2950_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1097\/00004583-199409000-00010","volume":"33","author":"B Black","year":"1994","unstructured":"Black B, Uhde TW (1994) Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 33:1000\u20131006. https:\/\/doi.org\/10.1097\/00004583-199409000-00010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2950_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/cap.1999.9.293","volume":"9","author":"JS Carlson","year":"1999","unstructured":"Carlson JS, Kratochwill TR, Johnston HF (1999) Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial. J Child Adolesc Psychopharmacol 9:293\u2013306. https:\/\/doi.org\/10.1089\/cap.1999.9.293","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2950_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/080394899427656","volume":"53","author":"GR Per Hove Thomsen","year":"1999","unstructured":"Per Hove Thomsen GR (1999) Elective mutism: a 17-year-old girl treated successfully with citalopram. Nord J Psychiatry 53:427\u2013429. https:\/\/doi.org\/10.1080\/080394899427656","journal-title":"Nord J Psychiatry"},{"key":"2950_CR26","doi-asserted-by":"publisher","DOI":"10.5174\/tutfd.2010.04056.1","author":"M Copur","year":"2010","unstructured":"Copur M, Gorker I, Demir T (2010) Ssri\u2019s for treatment of selective mutism. TUTFD. https:\/\/doi.org\/10.5174\/tutfd.2010.04056.1","journal-title":"TUTFD"},{"key":"2950_CR27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.brat.2013.07.003","volume":"51","author":"RL Bergman","year":"2013","unstructured":"Bergman RL, Gonzalez A, Piacentini J et al (2013) Integrated behavior therapy for selective mutism: a randomized controlled pilot study. Behav Res Ther 51:680\u2013689. https:\/\/doi.org\/10.1016\/j.brat.2013.07.003","journal-title":"Behav Res Ther"},{"key":"2950_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1037\/ccp0000422","volume":"87","author":"D Cornacchio","year":"2019","unstructured":"Cornacchio D, Furr JM, Sanchez AL et al (2019) Intensive group behavioral treatment (IGBT) for children with selective mutism: a preliminary randomized clinical trial. J Consult Clin Psychol 87:720\u2013733. https:\/\/doi.org\/10.1037\/ccp0000422","journal-title":"J Consult Clin Psychol"},{"key":"2950_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00787-018-1110-7","volume":"27","author":"B Oerbeck","year":"2018","unstructured":"Oerbeck B, Overgaard KR, Stein MB et al (2018) Treatment of selective mutism: a 5-year follow-up study. Eur Child Adolesc Psychiatry 27:997\u20131009. https:\/\/doi.org\/10.1007\/s00787-018-1110-7","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2950_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/camh.12045","volume":"19","author":"B Oerbeck","year":"2014","unstructured":"Oerbeck B, Stein MB, Wentzel-Larsen T et al (2014) A randomized controlled trial of a home and school-based intervention for selective mutism - defocused communication and behavioural techniques. Child Adolesc Ment Health 19:192\u2013198. https:\/\/doi.org\/10.1111\/camh.12045","journal-title":"Child Adolesc Ment Health"},{"key":"2950_CR31","unstructured":"American Medical Association (2022) ICD-10-CM 2023 the Complete Official Codebook. American Medical Association, Newburyport"},{"key":"2950_CR32","unstructured":"Statistisches Bundesamt (2022) Grunddaten der Krankenh\u00e4user: Fachserie 12 Reihe 6.1.1 2021. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Gesundheit\/Krankenhaeuser\/Publikationen\/Downloads-Krankenhaeuser\/grunddaten-krankenhaeuser-2120611217004.html"},{"key":"2950_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00103-023-03724-1","volume":"66","author":"R Schepker","year":"2023","unstructured":"Schepker R, K\u00f6lch M (2023) Die Versorgungslandschaft der Kinder- und Jugendpsychiatrie und -psychotherapie in Deutschland: Strukturen, Herausforderungen und Entwicklungen (The landscape of child and adolescent psychiatry and psychotherapy in Germany: structures, challenges, and developments). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 66:745\u2013751. https:\/\/doi.org\/10.1007\/s00103-023-03724-1","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"2950_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2215-0366(17)30127-X","volume":"4","author":"G Signorini","year":"2017","unstructured":"Signorini G, Singh SP, Boricevic-Marsanic V et al (2017) Architecture and functioning of child and adolescent mental health services: a 28-country survey in Europe. Lancet Psychiatry 4:715\u2013724. https:\/\/doi.org\/10.1016\/S2215-0366(17)30127-X","journal-title":"Lancet Psychiatry"},{"key":"2950_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","volume":"180","author":"Y Hayasaka","year":"2015","unstructured":"Hayasaka Y, Purgato M, Magni LR et al (2015) Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord 180:179\u2013184. https:\/\/doi.org\/10.1016\/j.jad.2015.03.021","journal-title":"J Affect Disord"},{"key":"2950_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M et al (2022) Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry 27:281\u2013295. https:\/\/doi.org\/10.1038\/s41380-021-01161-7","journal-title":"Mol Psychiatry"},{"key":"2950_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-05279-6","volume":"23","author":"M Koskela","year":"2023","unstructured":"Koskela M, St\u00e5hlberg T, Yunus WMAWM et al (2023) Long-term outcomes of selective mutism: a systematic literature review. BMC Psychiatry 23:779. https:\/\/doi.org\/10.1186\/s12888-023-05279-6","journal-title":"BMC Psychiatry"},{"key":"2950_CR38","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/jcpp.12333","volume":"56","author":"J Wertz","year":"2015","unstructured":"Wertz J, Zavos H, Matthews T et al (2015) Why some children with externalising problems develop internalising symptoms: testing two pathways in a genetically sensitive cohort study. J Child Psychol Psychiatry 56:738\u2013746. https:\/\/doi.org\/10.1111\/jcpp.12333","journal-title":"J Child Psychol Psychiatry"},{"key":"2950_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000444882","volume":"49","author":"A Gensthaler","year":"2016","unstructured":"Gensthaler A, Maichrowitz V, Kaess M et al (2016) Selective mutism: the fraternal twin of childhood social phobia. Psychopathology 49:95\u2013107. https:\/\/doi.org\/10.1159\/000444882","journal-title":"Psychopathology"},{"key":"2950_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/00004583-199507000-00007","volume":"34","author":"B Black","year":"1995","unstructured":"Black B, Uhde TW (1995) Psychiatric characteristics of children with selective mutism: a pilot study. J Am Acad Child Adolesc Psychiatry 34:847\u2013856. https:\/\/doi.org\/10.1097\/00004583-199507000-00007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2950_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cpr.2008.09.009","volume":"29","author":"AG Viana","year":"2009","unstructured":"Viana AG, Beidel DC, Rabian B (2009) Selective mutism: a review and integration of the last 15 years. Clin Psychol Rev 29:57\u201367. https:\/\/doi.org\/10.1016\/j.cpr.2008.09.009","journal-title":"Clin Psychol Rev"},{"key":"2950_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/MOP.0000000000000300","volume":"28","author":"A Hua","year":"2016","unstructured":"Hua A, Major N (2016) Selective mutism. Curr Opin Pediatr 28:114\u2013120. https:\/\/doi.org\/10.1097\/MOP.0000000000000300","journal-title":"Curr Opin Pediatr"},{"key":"2950_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1592\/phco.28.2.214","volume":"28","author":"Y Kaakeh","year":"2008","unstructured":"Kaakeh Y, Stumpf JL (2008) Treatment of selective mutism: focus on selective serotonin reuptake inhibitors. Pharmacotherapy 28:214\u2013224. https:\/\/doi.org\/10.1592\/phco.28.2.214","journal-title":"Pharmacotherapy"},{"key":"2950_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-65267-1","volume-title":"Neuro-\/Psychopharmaka Im Kindes- und Jugendalter: Grundlagen und Therapie","author":"M Gerlach","year":"2023","unstructured":"Gerlach M (2023) Neuro-\/Psychopharmaka Im Kindes- und Jugendalter: Grundlagen und Therapie, 4th edn. Springer, Berlin \/ Heidelberg, Berlin, Heidelberg","edition":"4"},{"key":"2950_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","volume":"42","author":"B Birmaher","year":"2003","unstructured":"Birmaher B, Axelson DA, Monk K et al (2003) Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 42:415\u2013423. https:\/\/doi.org\/10.1097\/01.CHI.0000037049.04952.9F","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2950_CR46","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","volume":"359","author":"JT Walkup","year":"2008","unstructured":"Walkup JT, Albano AM, Piacentini J et al (2008) Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 359:2753\u20132766. https:\/\/doi.org\/10.1056\/NEJMoa0804633","journal-title":"N Engl J Med"},{"key":"2950_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jaac.2018.01.015","volume":"57","author":"JR Strawn","year":"2018","unstructured":"Strawn JR, Mills JA, Sauley BA et al (2018) The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta-analysis. J Am Acad Child Adolesc Psychiatry 57:235-244.e2. https:\/\/doi.org\/10.1016\/j.jaac.2018.01.015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2950_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0278-5846(01)00236-6","volume":"26","author":"IM Varia","year":"2002","unstructured":"Varia IM, Cloutier CA, Doraiswamy PM (2002) Treatment of social anxiety disorder with citalopram. Prog Neuropsychopharmacol Biol Psychiatry 26:205\u2013208. https:\/\/doi.org\/10.1016\/s0278-5846(01)00236-6","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2950_CR49","unstructured":"(2002) Practical child and adolescent psychopharmacology. Cambridge child and adolescent psychiatry. Cambridge University Press, Cambridge, UK, New York, NY"},{"key":"2950_CR50","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jaac.2020.05.005","volume":"59","author":"HJ Walter","year":"2020","unstructured":"Walter HJ, Bukstein OG, Abright AR et al (2020) Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 59:1107\u20131124. https:\/\/doi.org\/10.1016\/j.jaac.2020.05.005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2950_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/PRBM.S274538","volume":"14","author":"P Muris","year":"2021","unstructured":"Muris P, Ollendick TH (2021) Current challenges in the diagnosis and management of selective mutism in children. Psychol Res Behav Manag 14:159\u2013167. https:\/\/doi.org\/10.2147\/PRBM.S274538","journal-title":"Psychol Res Behav Manag"},{"key":"2950_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1177\/1073191118787328","volume":"27","author":"A Gensthaler","year":"2020","unstructured":"Gensthaler A, Dieter J, Raisig S et al (2020) Evaluation of a novel parent-rated scale for selective mutism. Assessment 27:1007\u20131015. https:\/\/doi.org\/10.1177\/1073191118787328","journal-title":"Assessment"},{"key":"2950_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02637-6","volume":"20","author":"M Koskela","year":"2020","unstructured":"Koskela M, Chudal R, Luntamo T et al (2020) The impact of parental psychopathology and sociodemographic factors in selective mutism - a nationwide population-based study. BMC Psychiatry 20:221. https:\/\/doi.org\/10.1186\/s12888-020-02637-6","journal-title":"BMC Psychiatry"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02950-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-025-02950-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02950-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:20:18Z","timestamp":1781608818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-025-02950-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1007\/s00787-025-02950-z","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the University Hospital Frankfurt (17\/01\/2022, number 2022\u2013576). The university hospital\u2019s data security official granted the respective data protection approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Due to pseudonymisation and aggregate analysis of routinely collected hospital data, and in accordance with the national and EU legislation, and institutional requirements, written informed consent for this study was not required from the participants or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Due to pseudonymisation and aggregate analysis of routinely collected hospital data, and due to accordance with the national legislation and institutional requirements, written informed consent for publishing the study was not required from the participants or their legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CMF receives royalties for books in ADHD, ASD and MDD, and speaker's honoraria from clinical and teaching institutions for lectures on ASD. She has provided expert advice to the German Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) regarding ASD. Her research is supported through grants by EU, BMBF, DFG, Hessen-LOEWE, and the Reiss Endowment Frankfurt. Publications of SP are partially funded by the German Federal Ministry of Education and Research (BMBF) Network of University Medicine 2.0: \u201cNUM 2.0\", Grant No. 01KX2121, Projects: \"COVID-19 Research Infrastructure Platform for Children and Adolescents\u2014coverCHILD\" and \"NUM Routine Data Platform\u2014NUM-RDP\". The other authors declare no (non-) financial conflicts of interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}